Generex Biotechnology Corporation (PK:GNBT)

Business Focus: Bio Therapeutic Drugs

Latest 10 SEC filings (by transaction date) for GNBT within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET September 18th, 2019
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Sep 11/19 Sep 11/19 Prioletti Mark Joseph SE Direct Ownership Common Voting Shares Form 3 : Initial Statement of Beneficial Ownership of Securities    
May 14/19 May 14/19 Salvo Lawrence Anthony Sr Direct Ownership Common Stock, par value $.001 per share Form 3 : Initial Statement of Beneficial Ownership of Securities    
Dec 14/18 Dec 7/18 Haines Harold Gray Direct Ownership Common Stock P - Open market or private purchase 8,000 $1.05
Dec 14/18 Dec 7/18 Haines Harold Gray Direct Ownership Common Stock P - Open market or private purchase 300 $1.03
Dec 14/18 Dec 4/18 Haines Harold Gray Direct Ownership Common Stock P - Open market or private purchase 945 $2.12
Dec 14/18 Dec 4/18 Haines Harold Gray Direct Ownership Common Stock P - Open market or private purchase 555 $2.10
Oct 15/18 Oct 15/18 Ro Andrew Direct Ownership No Securities are benefically owned Form 3 : Initial Statement of Beneficial Ownership of Securities    
Oct 15/18 Oct 15/18 Purcell Richard David Jr. Direct Ownership No securities are benefically owned Form 3 : Initial Statement of Beneficial Ownership of Securities    
Oct 15/18 Oct 15/18 Lyman Gary Herbert Direct Ownership No securities are benfically owned Form 3 : Initial Statement of Beneficial Ownership of Securities    
Oct 15/18 Oct 15/18 Corrao Mark Direct Ownership No securities are beneficially owned Form 3 : Initial Statement of Beneficial Ownership of Securities    
Sign up or login above to see all SEC filings within the past 6 months.
Latest 10 SEC filings (by filing date) for GNBT within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET September 18th, 2019
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Sep 11/19 Sep 11/19 Prioletti Mark Joseph SE Direct Ownership Common Voting Shares Form 3 : Initial Statement of Beneficial Ownership of Securities    
May 14/19 May 14/19 Salvo Lawrence Anthony Sr Direct Ownership Common Stock, par value $.001 per share Form 3 : Initial Statement of Beneficial Ownership of Securities    
Dec 14/18 Dec 4/18 Haines Harold Gray Direct Ownership Common Stock P - Open market or private purchase 945 $2.12
Dec 14/18 Dec 4/18 Haines Harold Gray Direct Ownership Common Stock P - Open market or private purchase 555 $2.10
Dec 14/18 Dec 7/18 Haines Harold Gray Direct Ownership Common Stock P - Open market or private purchase 8,000 $1.05
Dec 14/18 Dec 7/18 Haines Harold Gray Direct Ownership Common Stock P - Open market or private purchase 300 $1.03
Oct 15/18 Oct 3/18 Ro Andrew Direct Ownership Stock Option (right to buy) A - Grant, award or other under Rule 16b-3(d) 4,500  
Oct 15/18 Oct 3/18 Purcell Richard David Jr. Direct Ownership Stock Option (right to buy) A - Grant, award or other under Rule 16b-3(d) 4,500  
Oct 15/18 Oct 3/18 Mcgee Brian Direct Ownership Stock Option (right to buy) A - Grant, award or other under Rule 16b-3(d) 1,000  
Oct 15/18 Oct 3/18 Lyman Gary Herbert Direct Ownership Stock Option (right to buy) A - Grant, award or other under Rule 16b-3(d) 1,000  
Sign up or login above to see all SEC filings within the past 6 months.
Sign up or login above to see the past 6 months of filings sorted by insider. .
Get holdings trends & enhanced insider charts in PDF now
Comment On!
140

Twitter

Search (past week) for $GNBT

StockTwits